Heidelberg Pharma AG Ratios and Metrics

Market cap in millions EUR. Fiscal year is December - November.

Millions EUR. Fiscal year is Dec - Nov.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Apr '26 Apr 29, 2026	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	2020 - 2016
Market Capitalization	130	136	112	129	266	177	Upgrade
Market Cap Growth	6.92%	21.70%	-13.03%	-51.73%	50.53%	9.59%	Upgrade
Enterprise Value	115	113	75	84	272	164	Upgrade
Last Close Price	2.78	2.91	2.40	2.76	5.72	5.18	Upgrade
PS Ratio	89.24	93.41	16.33	13.05	14.39	87.04	Upgrade
PB Ratio	-11.91	-12.47	3.62	2.61	4.00	26.43	Upgrade
P/TBV Ratio	-	-	5.08	3.18	4.62	-	Upgrade
EV/Sales Ratio	79.04	77.80	11.02	8.49	14.68	80.41	Upgrade
Debt / Equity Ratio	-0.01	-0.01	0.01	0.12	0.24	1.59	Upgrade
Net Debt / Equity Ratio	1.36	1.36	-0.95	-0.76	-0.98	0.67	Upgrade
Net Debt / EBITDA Ratio	0.31	0.31	1.39	1.40	3.69	-0.18	Upgrade
Net Debt / FCF Ratio	0.47	0.47	0.97	1.09	6.92	-0.16	Upgrade
Asset Turnover	0.03	0.03	0.11	0.12	0.30	0.10	Upgrade
Inventory Turnover	0.02	0.02	0.16	0.43	1.76	9.66	Upgrade
Quick Ratio	1.51	1.51	4.40	2.31	2.96	0.51	Upgrade
Current Ratio	2.53	2.53	5.95	2.86	3.15	0.60	Upgrade
Return on Equity (ROE)	-423.92%	-423.92%	-48.33%	-35.09%	-53.73%	-267.02%	Upgrade
Return on Assets (ROA)	-61.88%	-61.88%	-20.82%	-20.14%	-18.70%	-78.14%	Upgrade
Return on Capital Employed (ROCE)	-181.70%	-181.70%	-41.40%	-54.50%	-25.20%	-380.20%	Upgrade
Earnings Yield	-32.51%	-31.06%	-17.33%	-15.82%	-7.39%	-14.77%	Upgrade
FCF Yield	-24.40%	-23.31%	-26.86%	-26.91%	-3.55%	-15.74%	Upgrade
Buyback Yield / Dilution	-0.14%	-0.14%	-0.02%	-25.14%	-14.56%	-8.72%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.